Company intelligence / Profile preview

Silvi

Copenhagen, Denmarksilvi.ai ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Silvi offers an end-to-end AI-powered tool to accelerate systematic literature reviews and meta-analysis in healthcare and life sciences. It enables transparent, reproducible, and rapid evidence synthesis following established scientific guidelines such as Cochrane standards. The company’s solution automates screening and data extraction from scientific publications to support faster decision-making in research settings.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Ferring Pharmaceuticals (user testimonial/early adopter)

Beyond the preview

Go deeper on Silvi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Silvi.

Explore the full profile